Research progress of circRNA in silicosis fibrosis
Silicosis is a chronic progressive pulmonary fibrosis disease that seriously endangers the occupational health of workers. There is no effective treatment at present. It is urgent to find effective therapeutic targets and use molecular markers to intervene the process of silicosis fibrosis. As a new...
Main Authors: | Runan QIN, Xin WANG |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Committee of Journal of Environmental and Occupational Medicine
2022-05-01
|
Series: | 环境与职业医学 |
Subjects: | |
Online Access: | http://www.jeom.org/article/cn/10.11836/JEOM21407 |
Similar Items
-
A novel circRNA-SNP may increase susceptibility to silicosis
by: Zhounan Cheng, et al.
Published: (2022-09-01) -
Research progress of traditional Chinese medicine extracts in intervention of fibrosis caused by silicosis
by: Wenlu HANG, et al.
Published: (2022-02-01) -
From Basic Research to Clinical Practice: Considerations for Treatment Drugs for Silicosis
by: Rou Li, et al.
Published: (2023-05-01) -
Oridonin attenuates lung inflammation and fibrosis in silicosis via covalent targeting iNOS
by: Jingyan Gao, et al.
Published: (2022-09-01) -
Role of Circular RNAs in Pulmonary Fibrosis
by: Jian Zhou, et al.
Published: (2022-09-01)